Thus, the etiology of such obese patients with PCOS but with normal AMH levels (such as group 96 in Supplementary Table 2) might differ from that in normal weight PCOS patients with high AMH levels (such as group 16), so follow-up treatments should also be different. This evidence concerns the gene AMH and polycystic ovary syndrome.